Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · IEX Real-Time Price · USD
+0.060 (2.43%)
At close: Jul 12, 2024, 4:00 PM
-0.030 (-1.19%)
After-hours: Jul 12, 2024, 7:53 PM EDT

Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $90.70 million. The enterprise value is $51.21 million.

Market Cap 90.70M
Enterprise Value 51.21M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

CLRB has 35.85 million shares outstanding. The number of shares has increased by 160.60% in one year.

Shares Outstanding 35.85M
Shares Change (YoY) +160.60%
Shares Change (QoQ) +140.12%
Owned by Insiders (%) 3.20%
Owned by Institutions (%) 25.50%
Float 26.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.47
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.02.

Current Ratio 2.54
Quick Ratio n/a
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -1,855.60% and return on invested capital (ROIC) is -158.18%.

Return on Equity (ROE) -1,855.60%
Return on Assets (ROA) -245.60%
Return on Capital (ROIC) -158.18%
Revenue Per Employee n/a
Profits Per Employee -$2.55M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -60,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.56% in the last 52 weeks. The beta is 0.99, so CLRB's price volatility has been similar to the market average.

Beta (5Y) 0.99
52-Week Price Change +40.56%
50-Day Moving Average 2.97
200-Day Moving Average 3.05
Relative Strength Index (RSI) 44.23
Average Volume (20 Days) 509,540

Short Selling Information

The latest short interest is 2.27 million, so 6.34% of the outstanding shares have been sold short.

Short Interest 2.27M
Short Previous Month 2.37M
Short % of Shares Out 6.34%
Short % of Float 8.51%
Short Ratio (days to cover) 4.33

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -42.26M
Pretax Income -51.04M
Net Income -50.98M
EBITDA -50.75M
EBIT -51.04M
Earnings Per Share (EPS) -$3.08
Full Income Statement

Balance Sheet

The company has $40.03 million in cash and $548,343 in debt, giving a net cash position of $39.48 million or $1.10 per share.

Cash & Cash Equivalents 40.03M
Total Debt 548,343
Net Cash 39.48M
Net Cash Per Share $1.10
Equity (Book Value) 26.17M
Book Value Per Share 0.73
Working Capital 25.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.55 million and capital expenditures -$885,671, giving a free cash flow of -$39.44 million.

Operating Cash Flow -38.55M
Capital Expenditures -885,671
Free Cash Flow -39.44M
FCF Per Share -$1.34
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -160.60%
Shareholder Yield -160.60%
Earnings Yield -56.21%
FCF Yield -43.49%

Analyst Forecast

The average price target for CLRB is $20.00, which is 690.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.00
Price Target Difference 690.51%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 22, 2022
Split Type Reverse
Split Ratio 1:10


Altman Z-Score n/a
Piotroski F-Score 3